Published in Biogerontology on October 31, 2012
The kinase p38 activated by the metabolic regulator AMPK and scaffold TAB1 drives the senescence of human T cells. Nat Immunol (2014) 1.23
WRN Mutation Update: Mutation Spectrum, Patient Registries, and Translational Prospects. Hum Mutat (2016) 0.86
Small molecule inhibition of p38 MAP kinase extends the replicative life span of human ATR-Seckel syndrome fibroblasts. J Gerontol A Biol Sci Med Sci (2013) 0.84
Senescence induced by RECQL4 dysfunction contributes to Rothmund-Thomson syndrome features in mice. Cell Death Dis (2014) 0.83
Werner syndrome: Clinical features, pathogenesis and potential therapeutic interventions. Ageing Res Rev (2016) 0.82
Partial lipodystrophy with severe insulin resistance and adult progeria Werner syndrome. Orphanet J Rare Dis (2013) 0.81
p38α MAPK regulates proliferation and differentiation of osteoclast progenitors and bone remodeling in an aging-dependent manner. Sci Rep (2017) 0.75
Nijmegen breakage syndrome fibroblasts expressing the C-terminal truncated NBN(p70) protein undergo p38/MK2-dependent premature senescence. Biogerontology (2014) 0.75
Recent Advances in Understanding Werner Syndrome. F1000Res (2017) 0.75
Dysfunction of the MDM2/p53 axis is linked to premature aging. J Clin Invest (2017) 0.75
A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A (1995) 32.89
Telomeres shorten during ageing of human fibroblasts. Nature (1990) 23.97
Extension of life-span by introduction of telomerase into normal human cells. Science (1998) 20.48
Structure and function of telomeres. Nature (1991) 14.82
A DNA damage checkpoint response in telomere-initiated senescence. Nature (2003) 12.55
Telomere reduction in human colorectal carcinoma and with ageing. Nature (1990) 11.24
Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A (1992) 10.19
Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell (1999) 6.98
Cellular senescence in aging primates. Science (2006) 6.24
Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci U S A (1994) 4.57
Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res (1997) 4.22
Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation (2002) 4.12
Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J Cell Sci (2005) 3.96
Dyskeratosis congenita in all its forms. Br J Haematol (2000) 3.89
In vivo loss of telomeric repeats with age in humans. Mutat Res (1991) 3.18
Accumulation of senescent cells in mitotic tissue of aging primates. Mech Ageing Dev (2006) 3.14
Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27. J Cell Sci (1997) 2.80
Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence. Mol Cell Biol (2002) 2.70
A mouse model of ATR-Seckel shows embryonic replicative stress and accelerated aging. Nat Genet (2009) 2.68
Leukemia and lymphoma in ataxia telangiectasia. Blood (1996) 2.65
p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype. EMBO J (2011) 2.61
Werner and Hutchinson-Gilford progeria syndromes: mechanistic basis of human progeroid diseases. Nat Rev Mol Cell Biol (2007) 2.56
Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype-phenotype relationship. Neuroscience (2007) 2.55
Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci U S A (1995) 2.40
Relationship between donor age and the replicative lifespan of human cells in culture: a reevaluation. Proc Natl Acad Sci U S A (1998) 2.36
Replicative senescence: an old lives' tale? Cell (1996) 2.32
ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage. DNA Repair (Amst) (2002) 2.30
Mitogen-activated protein kinase p38 defines the common senescence-signalling pathway. Genes Cells (2003) 2.28
Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells. Circ Res (1997) 2.27
Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts. Nat Genet (2000) 2.26
Cockayne syndrome and xeroderma pigmentosum. Neurology (2000) 2.24
Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita. Genes Dev (2006) 2.20
Seckel syndrome exhibits cellular features demonstrating defects in the ATR-signalling pathway. Hum Mol Genet (2004) 1.95
The establishment of telomerase-immortalized cell lines representing human chromosome instability syndromes. Hum Mol Genet (2000) 1.93
Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas. Hum Pathol (2001) 1.88
High intensity ras signaling induces premature senescence by activating p38 pathway in primary human fibroblasts. J Biol Chem (2003) 1.76
The disparity between human cell senescence in vitro and lifelong replication in vivo. Nat Biotechnol (2002) 1.69
An overview of three new disorders associated with genetic instability: LIG4 syndrome, RS-SCID and ATR-Seckel syndrome. DNA Repair (Amst) (2004) 1.60
What can progeroid syndromes tell us about human aging? Science (2004) 1.53
Smooth muscle cell depletion and collagen types in progeric arteries. Cardiovasc Pathol (2001) 1.53
p53-dependent ICAM-1 overexpression in senescent human cells identified in atherosclerotic lesions. Lab Invest (2005) 1.49
Role of oxidative stress in telomere shortening in cultured fibroblasts from normal individuals and patients with ataxia-telangiectasia. Hum Mol Genet (2003) 1.48
Aging of Hutchinson-Gilford progeria syndrome fibroblasts is characterised by hyperproliferation and increased apoptosis. Exp Gerontol (2004) 1.44
Familial microcephaly with normal intelligence, immunodeficiency, and risk for lymphoreticular malignancies: a new autosomal recessive disorder. Am J Med Genet (1985) 1.44
Constitutive p38HOG mitogen-activated protein kinase activation induces permanent cell cycle arrest and senescence. Cancer Res (2002) 1.37
Suppression of proliferative defects associated with processing-defective lamin A mutants by hTERT or inactivation of p53. Mol Biol Cell (2008) 1.32
Progeria: a human-disease model of accelerated aging. Am J Clin Nutr (1992) 1.29
Prevention of accelerated cell aging in Werner syndrome using a p38 mitogen-activated protein kinase inhibitor. J Gerontol A Biol Sci Med Sci (2005) 1.24
Characterization of ataxia telangiectasia fibroblasts with extended life-span through telomerase expression. Oncogene (2001) 1.18
Cellular senescence, ageing and disease. Age (Dordr) (2008) 1.17
Dysadipocytokinemia in werner syndrome and its recovery by treatment with pioglitazone. Diabetes Care (2004) 1.14
Telomerase expression prevents replicative senescence but does not fully reset mRNA expression patterns in Werner syndrome cell strains. FASEB J (2001) 1.11
What geriatricians should know about the Werner syndrome. J Am Geriatr Soc (1999) 1.07
Shared phenotypes among segmental progeroid syndromes suggest underlying pathways of aging. J Gerontol A Biol Sci Med Sci (2005) 1.04
Genetic alterations in accelerated ageing syndromes. Do they play a role in natural ageing? Int J Biochem Cell Biol (2004) 1.03
Werner Syndrome as an example of inflamm-aging: possible therapeutic opportunities for a progeroid syndrome? Rejuvenation Res (2006) 1.02
Telomere-based proliferative lifespan barriers in Werner-syndrome fibroblasts involve both p53-dependent and p53-independent mechanisms. J Cell Sci (2003) 0.98
Possible new variant of Nijmegen breakage syndrome. Am J Med Genet (1996) 0.97
Fibroblast clones from patients with Hutchinson-Gilford progeria can senesce despite the presence of telomerase. Exp Gerontol (2004) 0.96
Assessing the role of stress signalling via p38 MAP kinase in the premature senescence of ataxia telangiectasia and Werner syndrome fibroblasts. Biogerontology (2008) 0.94
Prevention of accelerated cell aging in the Werner syndrome. Ann N Y Acad Sci (2006) 0.93
Expression of interleukin-1 alpha and beta in early passage fibroblasts from aging individuals. Exp Gerontol (1994) 0.92
Inhibition of NF-kappa B by pyrrolidine dithiocarbamate blocks endothelial cell activation. Biochem Biophys Res Commun (1995) 0.91
Characterization of cell cycle checkpoint responses after ionizing radiation in Nijmegen breakage syndrome cells. Cancer Res (1998) 0.89
Synthesis of the highly selective p38 MAPK inhibitor UR-13756 for possible therapeutic use in Werner syndrome. Future Med Chem (2010) 0.88
Growth of cultured cells from patients with ataxia-telangiectasia. J Cell Physiol (1976) 0.86
Long-term caloric restriction delays age-related decline in proliferation capacity of murine lens epithelial cells in vitro and in vivo. Invest Ophthalmol Vis Sci (1997) 0.84
Increased blood plasminogen activator inhibitor-1 and intercellular adhesion molecule-1 as possible risk factors of atherosclerosis in Werner syndrome. Gerontology (1997) 0.83
Can we intervene in human ageing? Expert Rev Mol Med (2009) 0.82
Genetic effects on the longevity of cultured human fibroblasts. II. DNA repair deficient syndromes. Gerontology (1983) 0.81
Activation of p38 MAP kinase and stress signalling in fibroblasts from the progeroid Rothmund-Thomson syndrome. Age (Dordr) (2012) 0.81
A model for the phenotypic presentation of Werner's syndrome. Exp Gerontol (2002) 0.80
Extensive allelic variation and ultrashort telomeres in senescent human cells. Nat Genet (2003) 3.77
High-throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and switched memory B-cell populations. Blood (2010) 2.37
B-cell diversity decreases in old age and is correlated with poor health status. Aging Cell (2008) 2.15
Fibroblast dysfunction is a key factor in the non-healing of chronic venous leg ulcers. J Invest Dermatol (2008) 1.93
Telomere instability in the male germline. Hum Mol Genet (2005) 1.55
What can progeroid syndromes tell us about human aging? Science (2004) 1.53
Vaccination-induced changes in human B-cell repertoire and pneumococcal IgM and IgA antibody at different ages. Aging Cell (2011) 1.51
Reversible senescence in human CD4+CD45RA+CD27- memory T cells. J Immunol (2011) 1.46
Age-Related Changes in Human Peripheral Blood IGH Repertoire Following Vaccination. Front Immunol (2012) 1.39
Gene profile analysis implicates Klotho as an important contributor to aging changes in brain white matter of the rhesus monkey. Glia (2008) 1.37
Structural stability and chromosome-specific telomere length is governed by cis-acting determinants in humans. Hum Mol Genet (2006) 1.30
The relationship between CD27 negative and positive B cell populations in human peripheral blood. Front Immunol (2011) 1.27
Prevention of accelerated cell aging in Werner syndrome using a p38 mitogen-activated protein kinase inhibitor. J Gerontol A Biol Sci Med Sci (2005) 1.24
Mechanisms of immunosenescence. Immun Ageing (2009) 1.19
p16/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: possible implications for melanoma progression. J Natl Cancer Inst (2003) 1.16
Normality of oligonucleotide microarray data and implications for parametric statistical analyses. Bioinformatics (2003) 1.14
DNA repair genes are selectively mutated in diffuse large B cell lymphomas. J Exp Med (2013) 1.12
Crosslinking and G-protein functions of transglutaminase 2 contribute differentially to fibroblast wound healing responses. J Cell Sci (2004) 1.10
Microarray analysis of senescent vascular smooth muscle cells: A link to atherosclerosis and vascular calcification. Exp Gerontol (2009) 1.03
Werner Syndrome as an example of inflamm-aging: possible therapeutic opportunities for a progeroid syndrome? Rejuvenation Res (2006) 1.02
The role of cellular senescence in Werner syndrome: toward therapeutic intervention in human premature aging. Ann N Y Acad Sci (2007) 0.98
Telomere-based proliferative lifespan barriers in Werner-syndrome fibroblasts involve both p53-dependent and p53-independent mechanisms. J Cell Sci (2003) 0.98
Fibroblast clones from patients with Hutchinson-Gilford progeria can senesce despite the presence of telomerase. Exp Gerontol (2004) 0.96
Assessing the role of stress signalling via p38 MAP kinase in the premature senescence of ataxia telangiectasia and Werner syndrome fibroblasts. Biogerontology (2008) 0.94
Telomeres and telomerase biology in vertebrates: progress towards a non-human model for replicative senescence and ageing. Biogerontology (2005) 0.93
Prevention of accelerated cell aging in the Werner syndrome. Ann N Y Acad Sci (2006) 0.93
The extent and significance of telomere loss with age. Ann N Y Acad Sci (2004) 0.91
Text-based over-representation analysis of microarray gene lists with annotation bias. Nucleic Acids Res (2009) 0.90
Evaluating the role of p38 MAP kinase in growth of Werner syndrome fibroblasts. Ann N Y Acad Sci (2010) 0.90
Normal telomere erosion rates at the single cell level in Werner syndrome fibroblast cells. Hum Mol Genet (2004) 0.90
Replicative senescence in sheep fibroblasts is a p53 dependent process. Exp Gerontol (2005) 0.88
Synthesis of the highly selective p38 MAPK inhibitor UR-13756 for possible therapeutic use in Werner syndrome. Future Med Chem (2010) 0.88
Microwave-assisted Ullmann C-S bond formation: synthesis of the P38alpha MAPK clinical candidate VX-745. J Org Chem (2009) 0.87
Characterization of cellular senescence mechanisms in human corneal endothelial cells. Aging Cell (2011) 0.86
Synthesis and in vivo activity of MK2 and MK2 substrate-selective p38alpha(MAPK) inhibitors in Werner syndrome cells. Bioorg Med Chem Lett (2007) 0.86
Direct evidence from siRNA-directed "knock down" that p16(INK4a) is required for human fibroblast senescence and for limiting ras-induced epithelial cell proliferation. Exp Cell Res (2004) 0.86
Microwave-assisted synthesis of N-pyrazole ureas and the p38alpha inhibitor BIRB 796 for study into accelerated cell ageing. Org Biomol Chem (2006) 0.86
Telomere erosion triggers growth arrest but not cell death in human cancer cells retaining wild-type p53: implications for antitelomerase therapy. Oncogene (2004) 0.85
Small molecule inhibition of p38 MAP kinase extends the replicative life span of human ATR-Seckel syndrome fibroblasts. J Gerontol A Biol Sci Med Sci (2013) 0.84
Investigating the role of c-Jun N-terminal kinases in the proliferation of Werner syndrome fibroblasts using diaminopyridine inhibitors. Chem Cent J (2011) 0.83
Resveratrol, but not dihydroresveratrol, induces premature senescence in primary human fibroblasts. Age (Dordr) (2011) 0.82
The effect of small-molecule inhibition of MAPKAPK2 on cell ageing phenotypes of fibroblasts from human Werner syndrome. Chem Cent J (2013) 0.82
Telomere-based therapy for immunosenescence. Trends Immunol (2002) 0.82
Activation of p38 MAP kinase and stress signalling in fibroblasts from the progeroid Rothmund-Thomson syndrome. Age (Dordr) (2012) 0.81
Gram-scale synthesis of the p38α MAPK-inhibitor VX-745 for preclinical studies into Werner syndrome. Future Med Chem (2010) 0.81
A P53-dependent, telomere-independent proliferative life span barrier in human astrocytes consistent with the molecular genetics of glioma development. Cancer Res (2003) 0.81
Identification of a transcriptional signature for the wound healing continuum. Wound Repair Regen (2014) 0.80
An analysis of replicative senescence in dermal fibroblasts derived from chronic leg wounds predicts that telomerase therapy would fail to reverse their disease-specific cellular and proteolytic phenotype. Exp Cell Res (2003) 0.80
Microwave-assisted synthesis of 5-aminopyrazol-4-yl ketones and the p38(MAPK) inhibitor RO3201195 for study in Werner syndrome cells. Bioorg Med Chem Lett (2008) 0.80
Rapid synthesis of VX-745: p38 MAP kinase inhibition in Werner syndrome cells. Bioorg Med Chem Lett (2007) 0.80
Modelling p-value distributions to improve theme-driven survival analysis of cancer transcriptome datasets. BMC Bioinformatics (2010) 0.80
Doxorubicin resistance in a novel in vitro model of human pleomorphic liposarcoma associated with alternative lengthening of telomeres. Mol Cancer Ther (2010) 0.79
Microwave-assisted synthesis of a pyrazolyl ketone library for evaluation as p38 MAPK inhibitors in Werner syndrome cells. Future Med Chem (2010) 0.77
Biomarkers, interventions and healthy ageing. N Biotechnol (2012) 0.77
Investigation of the signaling pathways involved in the proliferative life span barriers in werner syndrome fibroblasts. Ann N Y Acad Sci (2004) 0.76
Nijmegen breakage syndrome fibroblasts expressing the C-terminal truncated NBN(p70) protein undergo p38/MK2-dependent premature senescence. Biogerontology (2014) 0.75
Comparison of differential gene expression of hot and cold thyroid nodules with primary epithelial cell culture models by investigation of co-regulated gene sets. Biochim Biophys Acta (2006) 0.75
The effect of RO3201195 and a pyrazolyl ketone P38 MAPK inhibitor library on the proliferation of Werner syndrome cells. Org Biomol Chem (2015) 0.75